Viatris (VTRS) Assets Average (2020 - 2026)
Viatris (VTRS) posted Assets Average of $35.9 billion for Q2 2026, down 2.9% on a QoQ basis from $37.0 billion in Q1 2026, and down 6.51% year-over-year from $38.4 billion in Q2 2025.
Analysis
Viatris (VTRS) Assets Average (2020 - 2026) Analysis & Trends
Viatris has reported Assets Average for 7 years, with the latest figure at $35.9 billion in Q2 2026.
- On a quarterly basis, Assets Average fell 6.51% year-over-year to $35.9 billion in Q2 2026; TTM through Jun 2026 was $35.9 billion, a 6.51% decrease from a year earlier, with the FY2025 full-year figure at $39.3 billion, down 11.76% from the prior year.
- Assets Average was $35.9 billion for Q2 2026 at Viatris, down from $37.0 billion in the prior quarter.
- The five-year high for Assets Average was $54.2 billion in Q1 2022, with the low at $35.9 billion in Q2 2026.
- Average Assets Average over 5 years is $45.0 billion, with a median of $46.9 billion recorded in 2024.
- The sharpest annual moves came in 2023 and 2025: Assets Average retreated 2.29% in 2023, then slipped 17.04% in 2025.
- Over 5 years, Assets Average stood at $49.3 billion in 2022, then dropped by 2.29% to $48.2 billion in 2023, then dropped by 10.55% to $43.1 billion in 2024, then decreased by 12.92% to $37.6 billion in 2025, then decreased by 4.31% to $35.9 billion in 2026.
- The last three Assets Average figures came in at $35.9 billion (Q2 2026), $37.0 billion (Q1 2026), and $37.6 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | 39.95 Bn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | 35.94 Bn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | 6.21 Bn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | 3.66 Bn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | 24.65 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | 1.50 Bn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 1.46 Bn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | 1.70 Bn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | 73.15 Mn |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | 21.86 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 35.94 Bn |
| Mar 31, 2026 | 37.01 Bn |
| Dec 31, 2025 | 37.56 Bn |
| Sep 30, 2025 | 38.17 Bn |
| Jun 30, 2025 | 38.44 Bn |
| Mar 31, 2025 | 39.99 Bn |
| Dec 31, 2024 | 43.13 Bn |
| Sep 30, 2024 | 45.04 Bn |
| Jun 30, 2024 | 46.34 Bn |
| Mar 31, 2024 | 47.51 Bn |
| Dec 31, 2023 | 48.21 Bn |
| Sep 30, 2023 | 48.72 Bn |
| Jun 30, 2023 | 48.99 Bn |
| Mar 31, 2023 | 49.66 Bn |
| Dec 31, 2022 | 49.34 Bn |
| Sep 30, 2022 | 49.89 Bn |
| Jun 30, 2022 | 52.30 Bn |
| Mar 31, 2022 | 54.15 Bn |
| Dec 31, 2021 | 55.46 Bn |
| Sep 30, 2021 | 57.03 Bn |